Form 8-K Bunge Global SA For: Sep 17
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported)
___________________________________
(Exact name of registrant as specified in its charter)
___________________________________
(State of Incorporation) | ||
(Commission File Number) | (IRS Employer Identification Number) | |||||||
N.A | ||||||||
(Address of principal executive offices and zip code) | (Zip Code) | |||||||
1391 Timberlake Manor Parkway Chesterfield, MO | 63017 | |||||||
(Address of corporate headquarters ) | (Zip Code) | |||||||
( | ||||||||
(Registrant's telephone number, including area code) | ||||||||
N/A | ||||||||
(Former name or former address, if changed since last report) | ||||||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events
On September 17, 2026, Bunge Limited Finance Corp. (“BLFC”) and Bunge Finance Europe B.V. (“BFE”), both wholly owned subsidiaries of Bunge Global SA (“Bunge”), and their creditors agreed to extend three of Bunge’s revolving credit facilities as follows.
Effective as of October 2, 2026, BLFC, Bunge and the lenders under their existing unsecured $1.1 billion 364-day revolving credit agreement have extended the maturity date from October 2, 2026 to October 1, 2027.
Effective as of October 3, 2026, (i) BLFC, Bunge and the lenders under their existing unsecured $4.2 billion 5-year revolving credit agreement have extended the original termination date by a period of 12 months to October 3, 2031 and (ii) BFE, Bunge, and the lenders under their existing unsecured $3.5 billion 3-year revolving facility agreement have extended the original maturity date by a period of 12 months to October 3, 2029.
Item 9.01 Financial Statements and Exhibits
(d): Exhibits.
Exhibit No. | Description | ||||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: September 21, 2026
BUNGE GLOBAL SA | |||||
By: | /s/Lisa Ware-Alexander | ||||
Name: | Lisa Ware-Alexander | ||||
Title: | Secretary | ||||
ATTACHMENTS / EXHIBITS
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anyang Indorama Gases secures RMB 2.4 billion (c. US$358 million) long term financing for Fertilizer capacity expansion in Henan Province
- Meridian Mining's Definitive Feasibility Study for Cabaçal Delivers After-Tax NPV5 of USD 2.09 Billion, 108% IRR, and 0.9 Year Payback
- China Medical University Hospital Named to Newsweek's World's Best Specialized Hospitals 2027 for Neurosurgery
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share